Rhythm Pharmaceuticals Inc Sustainability Reports
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing precision medicines for rare neuroendocrine diseases. The company primarily targets genetic disorders associated with the melanocortin-4 receptor pathway to manage chronic, severe obesity and insatiable hunger.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900JPNWXQ8DPLA551
FIGI: BBG007DLZ629
3 reports from 2018 to 2023